A Study of Investigational Drug CFI-402257 in Patients With Advanced Solid Tumors (Q64151317)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A Study of Investigational Drug CFI-402257 in Patients With Advanced Solid Tumors |
clinical trial |
Statements
An Open Label, Dose Escalation, Safety, and Pharmacokinetic Study of CFI-402257 Administered Orally to Patients With Advanced Solid Tumors (English)
0 references
11 November 2016
0 references
January 2021
0 references
48
0 references
18 year
0 references